SKIN — Beauty Health Co Income Statement
0.000.00%
Last trade - 00:00- $124.03m
- $306.17m
- $334.29m
- 78
- 62
- 40
- 62
Annual income statement for Beauty Health Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 119 | 260 | 366 | 398 | 334 |
| Cost of Revenue | |||||
| Gross Profit | 67.2 | 179 | 249 | 193 | 210 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 136 | 300 | 392 | 529 | 369 |
| Operating Profit | -17.2 | -39.9 | -25.8 | -131 | -34.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -38.5 | -381 | 45.3 | -102 | -29.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -29.2 | -379 | 44.2 | -100 | -29.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -29.2 | -379 | 44.2 | -100 | -29.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -29.2 | -379 | 44.2 | -100 | -29.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.01 | -3.71 | 0.298 | -0.538 | -0.263 |